تجاوز إلى المحتوى الرئيسي
drug protocol number
D8221C00001
drug sponsor
Acerta Pharma BV
drug study
Acalabrutinib
drug trial site
King Fahad Specialist Hospital (Dammam)
drug status
Ongoing
drug phase